Cancer and Blood Disorders Center

Strong Against Cancer

Strong Against CancerStrong Against Cancer was a fundraising initiative inspired by research discoveries in immunotherapy at Seattle Children’s. Through the initiative’s philanthropic support, Seattle Children’s created one of the most diverse and robust pipelines of open T-cell immunotherapy clinical trials for children and young adults in the world.

Thanks to the generous community and people like you, Strong Against Cancer reached its bold fundraising goal of $100 million in 2019! This achievement was made possible because of your dedication to accelerating life-saving research for kids with cancer.

While the initiative has reached its fundraising goal, Seattle Children’s is more committed than ever to finding cures for childhood cancer and we need your help.

How to Get Involved

Donate Now

Support the advancement of immunotherapy and cancer research at Seattle Children’s.

Host a Fundraiser

Fundraise for cancer research at Seattle Children’s. Check out our useful tips to make it easy and fun or reach out to us to get started. 

If you are currently hosting or planning a fundraiser for Strong Against Cancer, please email us.

Get Your Company Involved

From sponsoring an event to organizing a workplace fundraiser, there are many meaningful ways your business or company can support cancer research at Seattle Children’s. Learn more or email us.

Patients Inspire Our Work Every Day

Seattle Children’s cancer immunotherapy clinical trials have impacted the lives of many children and young adults who had no other treatment options. We are grateful to every child that has participated in these breakthrough research trials. Please take a moment to hear from some of these inspiring patients who chose to share their stories with us.

Learn How T-cell Immunotherapy Works

Seattle Children’s is an international leader in research to cure childhood cancer by boosting the immune system with immunotherapy. We treat more types of relapsed or refractory childhood cancers using T-cell therapies than any other facility. Learn more.